PYY(3–36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity
Lists
Only you see this
Abstract
The gut hormone peptide YY (PYY) was recently proposed to comprise an endogenous satiety factor. We have studied acute anorectic functions of PYY(3-36) in mice and rats, as well as metabolic effects of chronic PYY(3-36) administration to diet-induced obese (DIO) mice and rats. A single intraperitoneal injection of PYY(3-36) inhibited food intake in mice, but not in rats. We next investigated the effects of increasing doses (100, 300, and 1,000 microg.kg-1.day-1) of PYY(3-36) administered subcutaneously via osmotic minipumps on food intake and body weight in DIO C57BL/6J mice. Whereas only the highest dose (1,000 microg.kg-1.day-1) of PYY(3-36) significantly reduced food intake over the first 3 days, body weight gain was dose dependently reduced, and on day 28 the group treated with 1,000 microg.kg-1.day-1 PYY(3-36) weighed approximately 10% less than the vehicle-treated group. Mesenteric, epididymal, retroperitoneal, and inguinal fat pad weight was dose dependently reduced. Subcutaneous administration of PYY(3-36) (250 and 1,000 microg.kg-1.day-1) for 28 days reduced body weight and improved glycemic control in glucose-intolerant DIO rats. Neither 250 nor 1,000 microg/kg PYY(3-36) elicited a conditioned taste aversion in male rats.
BibTeX
@inproceedings{vrang2006pyy,
author = {Niels Vrang and Andreas Nygaard Madsen and Mads Tang‐Christensen and Gitte Hansen and Philip J. Larsen},
title = {{PYY(3–36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity}},
booktitle = {American},
year = {2006},
doi = {10.1152/ajpregu.00726.2005},
}Loading related content...